Home
Live Updates
Ticagrelor Alone Cuts Bleeding Without More Events Post-PCI : comparemela.com
Ticagrelor Alone Cuts Bleeding Without More Events Post-PCI
Ticagrelor monotherapy safely cut bleeding by more than half after intervention for acute coronary syndrome, without an increase in MACCE, in the ULTIMATE-DAPT trial.
Related Keywords
United Kingdom ,
Nanjing ,
Jiangsu ,
China ,
Vienna ,
Wien ,
Austria ,
Italy ,
New York ,
United States ,
Virginia ,
Pakistan ,
Gloriam Steiner Gager ,
Shao Liang Chen ,
Jolantam Siller Matula ,
Wayne Batchelor ,
Icahn School Of Medicine ,
Vascular Institute ,
Academic Research Consortium ,
University Of Vienna ,
Mount Sinai Health System ,
Duke University ,
American College Of Cardiology Scientific Session ,
International Society On Thrombosis ,
New York City ,
Icahn School ,
American College ,
Cardiology Scientific Session ,
Nanjing Medical University ,
Nanjing First Hospital ,
Bleeding Academic Research Consortium ,
Occluded Arteries ,
International Society ,
Inova Heart ,
Medical University ,
Acute Coronary Syndrome Acs ,
Aspirin ,
Acetylsalicylic Acid ,
Thromboembolism ,
Cardiac Surgeries ,
Cardiac Surgery ,
Stroke Cerebrovascular Accident Cva ,
Hemorrhage ,
Bleeding ,
Stent ,
Drug Eluting Stent ,
Myocardial Infarction ,
Target Vessel Revascularization ,
Vr Target Vessel Revascularization ,
Thrombosis ,
Cv Risk ,
comparemela.com © 2020. All Rights Reserved.